Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Zivo Bioscience Partners to Boost Poultry Health with New Immune-Boosting Solution
24 June 2025

Zivo Bioscience Partners to Boost Poultry Health with New Immune-Boosting Solution

Zivo Bioscience Partnered with Animal Health Companies to Advance Poultry Image Credits: AInvest Announcement Zivo Bioscience, Inc., an agtech R&D and biotech company known for its nutritional products and development of therapeutic has partnered with a leading animal health company to inve...

Vertex and Ono Pharmaceutical Partner to Bring New Kidney Disease Treatment to Japan and South Korea
24 June 2025

Vertex and Ono Pharmaceutical Partner to Bring New Kidney Disease Treatment to Japan and South Korea

Vertex and Ono Pharmaceutical Entered into an Agreement Image Credits: Biospectrum Asia Announcement Vertex and Ono Pharmaceutical have signed a license agreement to develop and market Povetacicept in South Korea and Japan. Povetacicept is a therapeutic for various serious B-cell-mediated disea...

Medical Taiwan 2025 Highlights Smart Healthcare and AI Innovations for Ageing Population
23 June 2025

Medical Taiwan 2025 Highlights Smart Healthcare and AI Innovations for Ageing Population

Taiwan's Trade Show Introduced Smart Healthcare Image Credits: Techsauce Announcement The Taiwan External Trade Development Council held a medical trade show, Medical Taiwan 2025, which attracted 316 exhibitors from 14 countries. The show highlighted advanced technology products fueled by gover...

Superlab Suisse to Open New Life Sciences Lab at Geneva’s Campus Biotech by 2026
23 June 2025

Superlab Suisse to Open New Life Sciences Lab at Geneva’s Campus Biotech by 2026

Superlab Suisse in Geneva by 2026 Image Credits: Manufacturing Chemist Announcement Superlab Suisse has officially announced its fourth Swiss laboratory facility opening at Campus Biotech in Geneva. The new facility will be inaugurated by January 2026. The location will provide a vast space for...

FDA Approves Dupixent by Regeneron and Sanofi for Bullous Pemphigoid Treatment
23 June 2025

FDA Approves Dupixent by Regeneron and Sanofi for Bullous Pemphigoid Treatment

Regeneron and Sanofi Receive Approval for the Medication Image Credits: FirstWord Pharma Announcement Sanofi and Regeneron Pharmaceuticals, Inc. received approval for Dupixent (dupilumab), a medication for adults suffering from bullous pemphigoid (BP). The approval of this medication was based ...

MorningStar Expands SmartVascular Dx Heart Test Access to California Patients
23 June 2025

MorningStar Expands SmartVascular Dx Heart Test Access to California Patients

MorningStar’s Test Reached California Image Credits: AInvest Announcement MorningStar Laboratories, LLC (MSL), a global developer of precision diagnostic tests that analyze clinical needs, is proud to announce the availability of the Smartvascular Dx test (PULS Cardiac test) to patients i...

Brenus Pharma and InSphero Present Promising 3D Tumor Model Results for Colorectal Cancer Therapy
20 June 2025

Brenus Pharma and InSphero Present Promising 3D Tumor Model Results for Colorectal Cancer Therapy

Brenus Pharma and InSphero’s Presentation Presentation InSphero, a leader in 3D cell-based assay technologies, of Swiss and Brenus pharma, a French biotech known for its next-generation excellent immunotherapies, showcased data at the European Association for Cancer Research 2025 annual co...

Immuno Cure and PharmaJet Join Forces to Boost HIV Vaccine with Needle-Free Technology
20 June 2025

Immuno Cure and PharmaJet Join Forces to Boost HIV Vaccine with Needle-Free Technology

Immuno Cure and PharmaJet Collaborate to Advance a Vaccine Image Credits: Biospace Announcement Immuno Cure Biotech is a clinical-stage biotechnology group located in the Hong Kong Science Park, is initiating a collaboration with PharmaJet to examine the immunogenicity and safety of HIV therape...

Aptevo Therapeutics Announces $8 Million Share Purchase to Fuel Clinical Growth
20 June 2025

Aptevo Therapeutics Announces $8 Million Share Purchase to Fuel Clinical Growth

Aptevo Therapeutics Buys Shares According to Nasdaq Rules Image Credits: NBC4 Announcement Aptevo Therapeutics Inc. is a clinical-stage biotechnology company that develops novel immune-oncology therapeutics according to its proprietary ADAPTIR-FLEX and ADAPTIR platform technologies has declared...

QIAGEN and GENCURIX Team Up to Develop Digital PCR Oncology Tests
20 June 2025

QIAGEN and GENCURIX Team Up to Develop Digital PCR Oncology Tests

QIAGEN and GENCURIX Partner to Digitize the Healthcare Sector Announcement QIAGEN and GENCURIX partnered to develop oncology assays to perform on the QIAcuityDx platform. A platform popular for its excellent performance in the digital PCR system has been initiated for clinical diagnostics. GENCU...